Gaucher Disease Market Share by Manufacturers, Types and Current Scenario 2018-2025
© Rajesh Sinha
31st October 2018 - Global Gaucher Disease Market is classified on the basis of product type, type of treatment molecules, route of administration, dosage forms, end users, and geography. A rare inherited disorder that results from the deficiency of the enzyme glucocerebrosidase is known as Gaucher disease. The typical character of this disease is that there is deposition of fatty substances in body’s organs and tissues.
The signs and symptoms of Gaucher disease may differ widely among people. Some of the signs and symptoms of Gaucher disease include fatigue, enlarged liver and spleen, low platelet and haemoglobin counts,bone pain and fractures, etc. The diagnosis of Gaucher disease can be carried out by laboratory testing either by quantifying the level of the enzyme glucocerebrosidase or by DNA study of the GBA gene for the four most common GBA mutations.
Request a Sample Copy of Gaucher Disease Market Report @
https://www.millioninsights.com/industry-reports/gaucher-disease-market/request-sample
There are mainly three types of Gaucher disease. The mildest and most common type of Gaucher disease is Type 1. The type 1 disorder is also known as Nonneuronopathic Gaucher disease and it does not affect the nervous system.
Whereas, neuronopathic forms of Gaucher disease are Type 2 also called as acute infantile neuronopathic Gaucher disease and Type 3 also called as chronic neuronopathic Gaucher disease. These types of disorder affect the central nervous system and cause severe problems brain damage, seizures, respiratory problems, poor development, eye movement disorders, enlarged spleen & liver, bone problems, etc.
Gaucher Disease is also known as glucosylceramide lipidosis, cerebrosidelipidosis syndrome, kerasinlipoidosis, glucocerebrosidase deficiency, kerasinhistiocytosis, glucosylceramide beta-glucosidase deficiency, Gaucher splenomegaly, glucosylceramidase deficiency, Gaucher syndrome, glucocerebrosidosis, lipoid histiocytosis (kerasin type), Gaucher's disease, GD, glucosylcerebrosidelipidosis and kerasinthesaurismosis.
The factors that propel the growth of the Gaucher Disease Market include increasing research & development activities and special facility for orphan drugs. On the other hand, there are also factors that may hamper the growth of the market such as inadequate patient population as it is a rare disease. Gaucher Disease Market is classified on the basis of product type as enzyme replacement therapy and substrate reduction therapy.
Gaucher Disease Market is classified on the basis of type of treatment molecules as biologics, small molecules and others. Gaucher Disease Market is classified on the basis of route of administration as oral, and parenteral. Gaucher Disease Market is classified on the basis of dosage forms as solid, liquid and others.
The major manufacturers covered in this report
• Sanofi
• Shire
• Actelion Pharma
• Pfizer
• ISU Pharm
Market segment by Type, the product can be split into
• Enzyme Replacement Therapy
• Substrate Reduction Therapy
Market segment by Application, Gaucher Disease can be split into
• Non-Neuronopathic Gaucher Disease
• Neuronopathic Gaucher Disease
Access Gaucher Disease Market Report with TOC @ https://www.millioninsights.com/industry-reports/gaucher-disease-market
Market segment by Regions/Countries, this report covers
• United States
• EU
• Japan
• China
• India
• Southeast Asia
Visit Our Blog: https://marketfuturereports.wordpress.com
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Email: sales@millioninsights.com
The signs and symptoms of Gaucher disease may differ widely among people. Some of the signs and symptoms of Gaucher disease include fatigue, enlarged liver and spleen, low platelet and haemoglobin counts,bone pain and fractures, etc. The diagnosis of Gaucher disease can be carried out by laboratory testing either by quantifying the level of the enzyme glucocerebrosidase or by DNA study of the GBA gene for the four most common GBA mutations.
Request a Sample Copy of Gaucher Disease Market Report @
https://www.millioninsights.com/industry-reports/gaucher-disease-market/request-sample
There are mainly three types of Gaucher disease. The mildest and most common type of Gaucher disease is Type 1. The type 1 disorder is also known as Nonneuronopathic Gaucher disease and it does not affect the nervous system.
Whereas, neuronopathic forms of Gaucher disease are Type 2 also called as acute infantile neuronopathic Gaucher disease and Type 3 also called as chronic neuronopathic Gaucher disease. These types of disorder affect the central nervous system and cause severe problems brain damage, seizures, respiratory problems, poor development, eye movement disorders, enlarged spleen & liver, bone problems, etc.
Gaucher Disease is also known as glucosylceramide lipidosis, cerebrosidelipidosis syndrome, kerasinlipoidosis, glucocerebrosidase deficiency, kerasinhistiocytosis, glucosylceramide beta-glucosidase deficiency, Gaucher splenomegaly, glucosylceramidase deficiency, Gaucher syndrome, glucocerebrosidosis, lipoid histiocytosis (kerasin type), Gaucher's disease, GD, glucosylcerebrosidelipidosis and kerasinthesaurismosis.
The factors that propel the growth of the Gaucher Disease Market include increasing research & development activities and special facility for orphan drugs. On the other hand, there are also factors that may hamper the growth of the market such as inadequate patient population as it is a rare disease. Gaucher Disease Market is classified on the basis of product type as enzyme replacement therapy and substrate reduction therapy.
Gaucher Disease Market is classified on the basis of type of treatment molecules as biologics, small molecules and others. Gaucher Disease Market is classified on the basis of route of administration as oral, and parenteral. Gaucher Disease Market is classified on the basis of dosage forms as solid, liquid and others.
The major manufacturers covered in this report
• Sanofi
• Shire
• Actelion Pharma
• Pfizer
• ISU Pharm
Market segment by Type, the product can be split into
• Enzyme Replacement Therapy
• Substrate Reduction Therapy
Market segment by Application, Gaucher Disease can be split into
• Non-Neuronopathic Gaucher Disease
• Neuronopathic Gaucher Disease
Access Gaucher Disease Market Report with TOC @ https://www.millioninsights.com/industry-reports/gaucher-disease-market
Market segment by Regions/Countries, this report covers
• United States
• EU
• Japan
• China
• India
• Southeast Asia
Visit Our Blog: https://marketfuturereports.wordpress.com
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Email: sales@millioninsights.com